Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies. Issue 1 (January 2015) - Bogenberger, James M.; Delman, Devora; Hansen, Nanna; Valdez, Riccardo; Fauble, Veena; Mesa, Ruben A.; Tibes, Raoul